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Abstract 
Background:  To assess the accuracy of fine needle 
aspiration cytology and comparing it with 
histopathoogical examination of excised lesion. 
Methods:  In this  cross sectional study palpable 
breast lumps referred for FNAC were included. Fine 
needle was used to aspirate the palpable lump and 
spread on the frosted slides to make the smears. 
These smears were fixed in ethyl alcohol and 
stained. Diagnosis was given along with 
categorization of the lesion using an internationally 
recommended reporting format. Sensitivity, 
specificity and diagnostic accuracy of FNAC was 
calculated using 2 x 2 table keeping histopathology 
as gold standard and FNAC as test. 
Results: Out of 73 patients majority (93%) were 
females. Age ranged between 10 to 80 years with 
mean age of 38 years (± 17). Right breast was 
involved in 66% cases and bilateralism was seen in 
4%. Definite diagnosis was given in 85% cases with 
63% reported as benign and 22% reported as 
malignant. There were no false positive cases and 
two false negative cases were reported. Sensitivity 
and specificity of breast FNAC in the diagnosis of 
malignancy was found to be 89% and 100 % 
respectively 
Conclusion: FNAC of palpable breast lumps is a 
reliable method for early diagnosis and management 
of lesions and the false negative results can be 
eliminated by examining the slides carefully before 
giving a negative diagnosis. 
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Introduction 
    History of fine needle aspiration cytology (FNAC) 
dates back to middle of nineteenth century. Kun and 
Lebert used to diagnose cancers by employing this 
technique.1,2 Only few pathologists were involved in 
these early days and mainly it was clinicians who used 
this simple technique. The procedure began to flourish 
almost one hundred years after the pioneer work.3,4  
      A palpable breast lesion is worrisome for both the 
patient and treating physician as the rate of breast 
carcinoma is increasing world over and Pakistan also 
has a very high prevalence rate.5 It is due to this very 
fact that early diagnosis of palpable breast lumps has 
become all the more important. FNAC is reliable, 
rapid and economical method and if combined with 
clinical impression and radiological findings 
(mammogram/ ultrasound) can lead to reliable 
diagnosis.6 This “triple approach” method leads to 
proper management of the patient. If all three 
modalities agree that lesion is benign or malignant, 
only then the lesion is managed as a benign or a 
malignant lesion.7 In case of disagreement by any one 
or two of the three, core needle biopsy/ lumpectomy 
should be performed. There has been concern about 
non diagnostic or inadequate nature of aspirates in 
FNACs of breast lumps but it can be reduced to a non 
significant level of the procedure is performed by the 
same pathologist who will report the case.8,9  
Patients and Methods  
This cross sectional validation study was carried out in 
Department of Pathology, Military Hospital Mangla 
from January 2009 to December 2009. All cases of 
palpable breast lumps referred for FNAC were 
included in the study. Uncooperative patients and 
patients which had previously gone through FNAC 
were not included in the study.The skin over the 
palpable lump was cleaned using alcohol or spirit 
swab by moving it in circular outward direction from 
the site of aspiration.  Aspiration was done with 24 
gauge needle. In all cases the lump was aspirated 
twice from two different sites. The aspirated material 
was spread on clean glass slides (frosted at one end). 
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The slides were immediately fixed in 95 % ethyl 
alcohol. Minimum of four slides of each case were 
made. Two were stained with Papanicolaou stain and 
two with Haematoxylin and Eosin stain. The slides 
were then examined under light microscope using x 4, 
x 10 and x 40 objective lenses. The diagnosis was given 
along with categorization of the lesion using an 
internationally recommended NHSBSP guidelines 
supplemented by a descriptive report.9 There are five 
categories according to this format. C1 represents a 
non diagnostic or inadequate aspirate and warrants a 
repeat FNAC. C2 is benign and the patient has to be 
followed up. C3 is atypia probably benign and C4 is 
suspicious for malignancy. C5 is mentioned in the 
report when there is definite evidence of malignancy. 
   The diagnosis given on FNAC was then recorded 
along with the diagnosis given on histopathology 
when the resected specimen was received later for 
each patient.Sensitivity, specificity and diagnostic 
accuracy of FNAC was calculated using 2 x 2 table 
keeping histopathology as gold standard and FNAC as 
test. 
Results 
    During the year 2009, palpable lump breast was the 
most common lesion for referral to the pathology 
department. There were total of 73 cases which 
constituted 32 % of the overall referral to the 
pathology department. Sixty Eight (93%) cases were 
females while 5 (7%) were males. Age ranged between 
10 to 80 years with mean age of 38 years (± 17). Right 
breast was involved in 48 (66%) cases, left breast in 22 
(30%) cases while bilateralism was seen in 3 (4%) 
cases. In majority (85%) of the cases, a definite 
diagnosis of either a benign or a malignant lesion was 
given. Forty six (63%) cases were reported as benign 
(C-2 category) including one case of chronic caseating 
granulomatous inflammation and 16 (22%) cases as 
malignant (C-5 category) (Table 1). Almost 1 out of 
every 5th case of palpable lump breast referred had 
malignancy. All patients with malignancy were 
women with more than 30 years of age and their 
median age was 43 years. Size of carcinoma ranged 
from 2.5 to7.5 cm with median size of 5 cm. Right 
breast was involved in 12 (75%) cases and left in 4 
(25%) cases. There were no false positive cases while 2 
false negative cases were reported. These two cases 
were reported as benign inflammatory lesions on 
FNAC. Later on lumpectomy was performed and 
histopathological examination of both cases revealed 
invasive ductal carcinoma. So the sensitivity and 
specificity of breast FNAC in the diagnosis of 
malignancy was found to be 89% and 100 % 
respectively using 2 x 2 table and the diagnostic 
accuracy was 97 % keeping histopathology diagnosis 
as gold standard (Table 2). 
Table 1. FNAC diagnosis of breast lumps 
Diagnostic category No (%) 
C – 1, Non diagnostic 09 (12%) 
C – 2, Benign 46 (63%) 
C – 3, Atypia probably benign 01 (1.5%) 
C – 4, Suspicious for malignancy 01 (1.5%) 
C – 5, Malignant neoplasm 16 (22%) 
Total 73 (100%) 
 
Table 2. Standard 2 x 2 contingency table of 
Breast FNAC using histopathology  diagnosis as 
gold standard 
FNACTest) 
Histopathology(Gold 
standard) 
Total 
Positive 
(Malignant) 
Negative 
(Benign) 
Positive 
(Malignant) 
16 0 16 
Negative 
(Benign) 
02 44 46 
Total 18 44 62 
 
Discussion 
    FNAC of a palpable lump breast when combined 
with triple approach is a well established method for 
evaluation of the breast lesions with diagnostic 
accuracy of over 99%.10-12 With early diagnosis, a 
patient’s chance of surviving breast cancer is higher 
than 90%. Late reporting with an advanced stage of 
disease is not an uncommon happening in our set up. 
Illiteracy and poor socioeconomic conditions can be 
held responsible for it. Pakistan has the highest rate of 
breast cancer for any Asian population accounting to 
40,000 deaths per year.13       
    The sensitivity for FNAC of breast lumps is 83.3% to 
97.0%.14-17 The specificity was 100% for Tiwari, Aziz et 
al and Hussain et al and 99.4% for Qingqing et al.14-17 
The results of these studies are comparable to our 
study with sensitivity in the range of 83% to 97% and 
specificity almost 100% for all the studies. In present 
study there were no false positive cases. Not all errors 
in medical diagnosis and treatment are necessarily 
malpractice because there are certain risks and 
margins for error that arise inherently in the practice 
of medicine.18 Surgical pathologists and 
cytopathologists are physicians, but they are humans 
too. They have as great a capacity for error and 
susceptibility to subjective distractions as other 
Journal of Rawalpindi Medical College (JRMC); 2015;19(1):41-43 
 
 43 
practitioners of the art of medicine. Clinicians believe 
that pathologists have all the ingredients to produce a 
statement of absolute truth given a small piece of 
tissue or aspirate, but even more dangerous to the 
mankind is the pathologist who also believes in this 
concept.19 In FNAC of breast lesions false positive 
diagnosis although rare has been committed in centers 
of excellence.20 Over a period of four years there were 
1104 cases reported as carcinoma by FNAC at the 
Royal Marsden Hospital and in four of these the 
diagnosis was subsequently proven to be benign. The 
benign conditions that led to false positive cytology 
diagnoses were radiation induced changes, 
granulomatous mastitis and fibroadenoma. The French 
institute of Curie, the state of art centre for cancer 
diagnosis has published their 44 years experience. 
They reported 23 false positive cases during this 
period. 
   False negative rate is generally less than 5 %.21,22 In 
our study there were 2 false negative (2.7%) cases. 
Both were females in their 6th decades of life and had 
single palpable lumps measuring 3 and 4 cm 
respectively in maximum diameters in right breast. 
The slides of these two cases were re examined. 
Aspirate was hypocellular and staining of slides was 
not of good quality. Scanty inflammatory infiltrate 
composed of neutrophils and histiocytes was seen. The 
diagnosis of a benign inflammatory lesion on a 
hypocellular aspirate with low quality slides should 
not have been given and rather the procedure should 
have been repeated. Both these cases were reported by 
only one pathologist and second opinion was not 
sought. Here it’s worth quoting what Stephen S. 
Sternberg wrote in the preface to the first edition of 
Sternberg’s diagnostic surgical pathology. “We speak 
of the loneliness of the long distance runner, but there 
may be no one lonelier than a surgical pathologist 
working solo” and “knowing when and what one 
doesn’t know is of singular importance”.23 Diagnostic 
consultation is strongly recommended in cases of 
slightest of diagnostic doubt.  
 
Conclusion 
1.FNAc of palpable breast lumps is a reliable method 
for early diagnosis and management of lesions.  
2.False negative results can be eliminated by carefully 
examining the slides,repeating the test if doubt 
emerges and consultation with another pathologist. 
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